Today: 19 April 2026
Singapore Airlines stock price: Air India pact in focus after C6L closes at S$6.35
18 January 2026
1 min read

Singapore Airlines stock price: Air India pact in focus after C6L closes at S$6.35

SINGAPORE, Jan 18, 2026, 15:33 (SGT) — The market has closed.

  • Singapore Airlines shares ended Friday at S$6.35, slipping 0.16%.
  • The carrier and Air India have inked a framework to enhance commercial cooperation, pending necessary approvals.
  • Attention now turns to the follow-up disclosures and SIA’s business update scheduled for Feb. 24.

Shares of Singapore Airlines Ltd (SGX:C6L) ended Friday at S$6.35, slipping 0.16%. The market remains closed Sunday.

The stock’s next direction might depend less on daily trading and more on whether a new partnership with Air India solidifies. Investors are keen to see if the airlines can expand their reach in India-Singapore travel and tap into higher-yield corporate customers without running afoul of regulations.

On Jan. 16 in Mumbai, Air India and Singapore Airlines inked a commercial cooperation framework that could pave the way for joint business agreements, allowing tighter coordination on schedules and fares—once regulators give the green light. The carriers already codeshare across 61 destinations in 20 countries and territories. Air India CEO Campbell Wilson described the deal as “a clear and structured platform” for deeper collaboration, while SIA CEO Goh Choon Phong called it “a natural evolution” of their partnership. Air India

Shareholders want to know how quickly this shifts from general talk to detailed route-by-route strategies, and who ends up controlling the corporate accounts. Large partnerships might boost load factors and pricing power, but they often take months to finalize.

Fuel remains a key focus for traders, with jet fuel typically the largest expense for airlines. Brent crude hovered near $64 a barrel on Friday, following a sharp decline the previous day. If prices stay here, it could relieve some cost pressures.

However, the Air India framework isn’t set in stone yet; regulators across several markets still need to approve any joint business plan. Oil prices can shift rapidly, and a sudden jump would immediately push costs higher.

Trading in Singapore picks up again Monday as investors eye any updates on timelines, route overlaps, or commercial terms. The finer points — like schedule coordination and loyalty perks — might move sentiment more than the big announcements.

Beyond the merger news, shares will still move on the usual airline factors: premium-cabin demand, cargo pricing, and currency fluctuations. Those elements often overshadow any partnership headlines pretty quickly.

February 24 is the next key date, as Singapore Airlines plans to release its fiscal third-quarter update. Investors will be watching closely for signals on yields, costs, and any developments regarding the Air India discussions.

Stock Market Today

  • Nordea Bank Abp's Mixed Share Performance and Valuation Analysis
    April 18, 2026, 10:42 PM EDT. Nordea Bank Abp (HLSE:NDA FI) exhibits mixed returns with a negative year-to-date but a 51.1% total return over one year, showing strong long-term momentum. The bank's share price closed at €16.02, slightly below the €16.55 analyst target and a fair value estimate of €17.03, suggesting it may be undervalued. Nordea is investing heavily in digital technologies and cybersecurity, aiming to improve net margins and fee income. However, potential risks include Nordic housing market weakness and rising regulatory costs. Investors are advised to weigh both upside potential and downside risks before making decisions, considering broader financial sector comparisons and market conditions.

Latest article

Why Definium Therapeutics’ LSD-Based Drug Has Wall Street Watching 2026

Why Definium Therapeutics’ LSD-Based Drug Has Wall Street Watching 2026

18 April 2026
Definium Therapeutics shares rose to $22.68 after Stifel and Piper Sandler initiated coverage with Buy ratings, citing late-stage trials of DT120, an LSD-based tablet for anxiety and depression. The company will host an investor day April 22 in New York to discuss upcoming Phase 3 data. DT120 is in four pivotal studies, with top-line results expected through 2026. Johnson & Johnson and Compass Pathways are advancing rival clinic-based psychiatric drugs.
Seatrium share price in focus after U.S. court revives Empire Wind; Feb 28 delivery watched
Previous Story

Seatrium share price in focus after U.S. court revives Empire Wind; Feb 28 delivery watched

Jardine Matheson stock: What to watch Monday as Mandarin Oriental exits SGX and buybacks roll on
Next Story

Jardine Matheson stock: What to watch Monday as Mandarin Oriental exits SGX and buybacks roll on

Go toTop